As of January 22, 2025, Valerio Therapeutics SA (ALVIO.PA) has a market cap of $13.595 million USD. According to our data, Valerio Therapeutics SA is ranked No.8749 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $13.60 M |
13.07%
|
Dec 31, 2024 | $12.02 M |
-54.55%
|
Dec 29, 2023 | $26.45 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
REGENXBIO
RGNX
|
$0.39 B |
-0.000 M
|
USA
|
Rocket Pharmaceuticals
RCKT
|
$1.11 B |
-0.000 M
|
USA
|
uniQure
QURE
|
$0.82 B |
0.000 M
|
Netherlands
|
Voyager Therapeutics
VYGR
|
$0.30 B |
-0.000 M
|
USA
|
Precision BioSciences
DTIL
|
$38.13 M |
0.000 M
|
USA
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
Fate Therapeutics
FATE
|
$0.15 B |
0.000 M
|
USA
|
Market Cap | = | ALVIO.PA Stock Price | * | ALVIO.PA Shares Outstanding |
= | $0.09 | * | 0.15 B | |
= | $13.60 M |